400 related articles for article (PubMed ID: 25909213)
1. Relationship between adiponectin, obesity and insulin resistance.
Balsan GA; Vieira JL; Oliveira AM; Portal VL
Rev Assoc Med Bras (1992); 2015; 61(1):72-80. PubMed ID: 25909213
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin: from obesity to cardiovascular disease.
Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C
Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061
[TBL] [Abstract][Full Text] [Related]
3. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
Gable DR; Hurel SJ; Humphries SE
Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
7. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.
Han SH; Sakuma I; Shin EK; Koh KK
Prog Cardiovasc Dis; 2009; 52(2):126-40. PubMed ID: 19732605
[TBL] [Abstract][Full Text] [Related]
8. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
9. Modulation of adiponectin as a potential therapeutic strategy.
Lim S; Quon MJ; Koh KK
Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin and cardiovascular disease: state of the art?
Szmitko PE; Teoh H; Stewart DJ; Verma S
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between adipose tissue and vasculature: role of adiponectin.
Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
[TBL] [Abstract][Full Text] [Related]
12. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.
Rabin KR; Kamari Y; Avni I; Grossman E; Sharabi Y
Expert Rev Cardiovasc Ther; 2005 May; 3(3):465-71. PubMed ID: 15889974
[TBL] [Abstract][Full Text] [Related]
14. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
16. Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk.
Tumminia A; Vinciguerra F; Parisi M; Graziano M; Sciacca L; Baratta R; Frittitta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212761
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin-Resistance in Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():415-441. PubMed ID: 28585210
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and Cognitive Decline.
Rizzo MR; Fasano R; Paolisso G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188008
[TBL] [Abstract][Full Text] [Related]
19. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.
Wang Y; Zhou M; Lam KS; Xu A
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):201-12. PubMed ID: 19466213
[TBL] [Abstract][Full Text] [Related]
20. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance.
Zhang H; Chen X; Aravindakshan J; Sairam MR
Endocrinology; 2007 Dec; 148(12):5667-79. PubMed ID: 17717050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
